Repository logo
Log In
  1. Home
  2. Unibas
  3. Publications
  4. In Vitro Assessment of the Formation of Ceftriaxone-Calcium Precipitates in Human Plasma
 
  • Details

In Vitro Assessment of the Formation of Ceftriaxone-Calcium Precipitates in Human Plasma

Date Issued
2011-01-01
Author(s)
Schmutz, Hans-Rudolf
Detampel, Pascal  
Bühler, Theo
Büttler, André
Gygax, Benjamin
Huwyler, Jörg  
DOI
10.1002/jps.22466
Abstract
Ceftriaxone is a third-generation cephalosporin antibiotic, which has a broad spectrum of bactericidal activity. Ceftriaxone is highly soluble as a sodium salt, but far less soluble as a calcium salt. Incompatibility of ceftriaxone with calcium and the possible formation of precipitates have been stated in the product label from early on. It was the objective of the present in vitro study to further assess the risk of precipitation of calcium-ceftriaxone in human plasma. Analytical methods were developed (high-performance liquid chromatography and flame atomic absorption spectroscopy) to quantitate calcium and ceftriaxone in human plasma supernatants and human plasma precipitates. Using high concentrations of ceftriaxone (10 mmol/l) and calcium (4.2 mmol/l) did not result in any precipitation after a 2-h incubation in human plasma at 37°C.
Under conditions of forced precipitations only formation of precipitation was observed. The identity of the precipitated material was confirmed by Energy Dispersive X-Ray Analysis and Fourier Transform Infrared Spectroscopy.
We conclude that calcium-ceftriaxone in human plasma has an apparent kinetic solubility product constant of greater than 0.42 x 10-4 (mol/l)2, which exceeds the normal thermodynamic solubility product in water by a factor of 26. Under these conditions, formation of plasma precipitates is unlikely.
University of Basel

edoc
Open Access Repository University of Basel

  • About edoc
  • About Open Access at the University of Basel
  • edoc Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement